Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Health and Life Sciences at the Edge: Improving the Accuracy of Medical Imaging Analysis with Artificial Intelligence

Medical imaging is pioneering the use of AI and analytics to improve the way healthcare is delivered. As the Head of Health Solutions for Intel’s Internet of Things Group, in the Health and Life Sciences and Emerging Technology organization, Alex Flores is uniquely qualified to talk about how AI and Edge technologies are…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Medical imaging is pioneering the use of AI and analytics to improve the way healthcare is delivered. As the Head of Health Solutions for Intel’s Internet of Things Group, in the Health and Life Sciences and Emerging Technology organization, Alex Flores is uniquely qualified to talk about how AI and Edge technologies are improving the accuracy of medical imaging analysis. This trend began about ten years ago and has accelerated rapidly over the past three years.

“In July of 2020, Intel conducted a survey of over 200 US healthcare leaders. We were looking at key technology trends and the way technology needs have changed post-COVID-19,” Flores said. “We learned that about 45% of the respondents were using, or planning to use, AI in 2020 before COVID-19. That percentage jumped to about 84% since the onset of COVID-19.”

Flores discussed the benefits and problems associated with integrating Edge technology and AI into medical imaging. While adding more compute to or next to devices can shorten the time needed for clinicians to do their jobs, it can also create challenges for manufacturers of Edge devices.

Edge computing is about doing more processing on or next to a device,” said Flores. “But when you add an external device, power consumption and acoustics become an issue. You can’t just stuff more power-hungry GPUs into an Edge device because they will increase fan size and noise. Imagine sitting in a clinician’s office reviewing your results but not being able to hear because the Edge server under their desk is too loud.”

It’s estimated that the health and life sciences industry produces about a third of the world’s data. But less than three percent of that data has been analyzed. Flores believes that by partnering with health and life sciences industry leaders to address the challenges of harnessing these vast amounts of data Intel can help them come up with actionable insights.

“In my opinion, we haven’t even scratched the surface of what is possible,” Flores said. “We work with our partners to architect optimum hardware platforms, then layer the right software tools to ensure that the solution is optimized to meet their needs. The exciting promise of AI in medical imaging is that it has progressed significantly and in my opinion is continuing to accelerate.”

Learn more about improving the accuracy of medical imaging analysis with AI by connecting with Alex Flores on LinkedIn or visit http://www.intel.com/healthcare

Subscribe to this channel on Apple Podcasts, Spotify, or Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

July partnerships show hospitals aligning without ownership change

July partnerships show hospitals aligning without ownership change

A July McDermott Will & Schulte analysis and four July partnership announcements tracked by Becker’s Hospital Review point to affiliation models that stop short of mergers. St. Christopher’s signed a nonbinding letter of intent with Nemours, Jefferson and Temple; Palomar UC San Diego Health began operating July 1 under a joint powers authority. Several announcements explicitly rule out ownership change, shifting the work to contracts covering governance and other terms.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Eye telemedicine hits limits without home retinal imaging

Eye telemedicine hits limits without home retinal imaging

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512